The effectiveness of a new antiviral drug of plant origin in the form of eye drops in the complex therapy of ophthalmic herpes

Ophthalmic herpes is the most common infection-related cause of blindness in developing countries.
Purpose: to evaluate the therapeutic efficacy, safety and tolerability of the drug Panavir® used as part of a combination therapy for herpetic superficial dendritic keratitis.
Materials and methods. The study involved 106 patients aged 18 to 65 years divided into two groups. Group 1 (54 patients; 54 eyes) received treatment with Panavir® and Acyclovir ophthalmic ointment, whilst Group 2 (52 patients; 52 eyes) received a placebo of Panavir® and Acyclovir ophthalmic ointment. The primary parameter of the efficiency was the percentage of patients achieving clinical recovery, i.e. signs of complete epithelialization of the cornea.
Results. In group 2 (monotherapy), a significantly greater number of patients with mild conjunctival hyperemia was registered than in the combination therapy group 1 — 59.26 vs. 23.08 %, p < 0.001. In group 1, the proportion of patients without corneal syndrome at visits 3 and 4 was, respectively, 11.11 and 61.11 %, while in group 2 it was only 3.85 and 19.61 %, respectively.
Conclusion. The drug Panavir® eye drops 0.004 % showed a high therapeutic efficiency in the combined treatment of herpetic keratitis, and good tolerance. It also reduced the time required for corneal epithelialization and conjunctiva normalization.

1. Darougar S, Wishart MS, Viswalingam ND. Epidemiological and clinical features of primary herpes simplex virus ocular infection. Br J Ophthalmol. 1985; 69 (1): 2–6. doi: 10.1136/bjo.69.1.2

2. Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea. 2001; 20 (1): 1–13. doi: 10.1097/00003226-200101000-00001

3. Souza PM, Holland EJ, Huang AJ. Bilateral herpetic keratoconjunctivitis. Ophthalmology. 2003; 110 (3): 493–6. doi: 10.1016/S0161-6420(02)01772-4

4. Neroev V.V., Vakhova E.S. Diseases of the conjunctiva. In: Ophthalmology. National Guide. Moscow: GEОTAR-Media; 2018: 418–61 (In Russ.).

5. Kaswin G, Rousseau A, M’Garrech M, et al. Optical aberrations in patients with recurrent herpes simplex keratitis and apparently normal vision. Br J Ophthalmol. 2013; 97 (9): 1113–7. doi: 10.1136/bjophthalmol-2012-302294

6. Yani E.V., Seliverstova K.E. Conservative treatment of neurotrophic keratitis. Medical Council. 2017; 5: 162–166 (In Russ.). doi:10.21518/2079-701X-2017-5-162-166

7. Liesegang TJ. Epidemiology and natural history of ocular herpes simplex virus infection in Rochester. Minnesota, 1950–1982. Trans Am Ophthalmol Soc. 1988; 86: 688–724. doi: 10.1001/archopht.1989.01070020221029

8. Labetoulle M, Auquier P, Conrad H, et al. Incidence of herpes simplex virus keratitis in France. Ophthalmology. 2005; 112: 888–95. doi: 10.1016/j.ophta.2004.11.052

9. Young RC, Hodge DO, Liesegang TJ, Baratz KH. Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976–2007: the effect of oral anti-viral prophylaxis. Arch Ophthalmol. 2010; 128 (9): 1178–83. doi: 10.1001/archophthalmol.2010.187

10. Tsatsos M, MacGregor C, Athanasiadis I, et al. Herpes simplex virus keratitis: an update of the patho- genesis and current treatment with oral and topical antiviral agents. Clin Exp Ophthalmol. 2017; 45 (9): 932. doi: 10.1111/ceo.12991

11. Azher T, Yin X, Tajfirouz D, Huang A, Stuart P. Herpes simplex keratitis: challenges in diagnosis and clinical management. Clin Ophthalmol. 2017; 11: 185–91. doi: 10.2147/OPTH.S80475

12. Kodama T, Hayasaka S, Setogawa T. Immunofluorescent staining and corneal sensitivity in patients suspected of having herpes simplex keratitis. Arch Ophthalmol. 1992; 113 (2): 187–9. doi: 10.1016/s0002-9394(14)71532-6

13. Klimova R.R., Kushch A.A., Fedorova N.E., Litvin A.A. Effect of Panavir on Herpes simplex virus types 1 and 2 proteins synthesis in cell culture. Antibiotics and Chemotherapy. 2009; 54 (3–4): 18–20 (In Russ.).

14. Alimbarova L.M., Lazarenko A.A., Kiselev A.V., et al. Evaluating the effectiveness of Solanum tuberosum shoots extract in experimental ocular herpes. Vestnik Oftal’mologii. 2015; 131 (3): 76–81 (In Russ.). doi:10.17116/oftalma2015131376-81